THE MALIGNANT PHASE OF ESSENTIAL HYPERTENSION IN JOHANNESBURG BLACKS. A PROSPECTIVE STUDYJHETAM D; DANSEY R; MORAR C et al.1982; S. AFR. MED. J.; ISSN 0038-2469; ZAF; DA. 1982; VOL. 61; NO 24; PP. 899-902; BIBL. 11 REF.Article

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer : a randomized trialBEZWODA, W. R; SEYMOUR, L; DANSEY, R. D et al.Journal of clinical oncology. 1995, Vol 13, Num 10, pp 2483-2489, issn 0732-183XArticle

Captopril in hypertensive black men in southern AfricaCOWIE, R. L; DANSEY, R. D.SAMJ. South African medical journal. 1990, Vol 78, Num 8, pp 455-456, issn 0256-9574, 2 p.Article

Seizures and neurocysticercosis in black menDANSEY, R. D; HAY, M; COWIE, R. L et al.SAMJ. South African medical journal. 1992, Vol 81, Num 8, pp 424-425, issn 0256-9574Article

Biology of disease and clinical aspects of AIDS-associated lymphoma : a reviewSTEIN, M. E; SPENCER, D; DANSEY, R et al.East African medical journal. 1994, Vol 71, Num 4, pp 219-222, issn 0012-835XArticle

Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancerBEZWODA, W. R; SEYMOUR, L; DANSEY, R et al.Cancer. 1989, Vol 64, Num 5, pp 1029-1033, issn 0008-543X, 5 p.Article

P-glycoprotein immunostraining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancerSEYMOUR, L; BEZWODA, W. R; DANSEY, R. D et al.Breast cancer research and treatment. 1995, Vol 36, Num 1, pp 61-69, issn 0167-6806Article

TINlib in a further education college library: a student viewpointDANSEY, R; GILL, A; JONES, C et al.VINE. Very informal newsletter on library automation. 1993, Num 92, pp 12-16, issn 0305-5728Article

High-dose Chemotherapy and Adoptive Immunotherapy in the Treatment of Recurrent Pediatric Brain TumorsPERES, E; WOOD, G. W; POULIK, J et al.Neuropediatrics. 2008, Vol 39, Num 3, pp 151-156, issn 0174-304X, 6 p.Article

High fatality rate of epstein-barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimensPERES, E; SAVASAN, S; KLEIN, J et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 7, pp 3540-3543, issn 0095-1137, 4 p.Article

Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancerCHANDRASEKAR, P. H; ABRAHAM, O. C; BAYNES, R et al.Clinical infectious diseases. 2001, Vol 32, Num 4, pp 546-551, issn 1058-4838Conference Paper

Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2 (Sf) growing in serum-free conditions : growth characteristics, biochemical, and cytogenetic studiesGOLOMBICK, T; DANSEY, R; BEZWODA, W. R et al.In vitro cellular & developmental biology. 1990, Vol 26, Num 5, pp 447-454, issn 0883-8364, 8 p.Article

Breast cancer in men: clinical features, hormone receptor status, and response to therapyBEZWODA, W. R; HESDORFFER, C; DANSEY, R et al.Cancer. 1987, Vol 60, Num 6, pp 1337-1340, issn 0008-543XArticle

Bone marrow and peripheral blood hematopoietic stem cell transplantation : Focus on autograftingBAYNES, R. D; HAMM, C; DANSEY, R et al.Clinical chemistry (Baltimore, Md.). 2000, Vol 46, Num 8, pp 1239-1251, issn 0009-9147, 2Conference Paper

Lymphoproliferative disorders in non-AIDS-associated Kaposi's sarcoma : the Johannesburg Hospital experience, 1980-1992STEIN, M. E; SPENCER, D; DANSEY, R et al.SAMJ. South African medical journal. 1994, Vol 84, Num 8, pp 484-488, issn 0256-9574, 1Article

Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trialDERMAN, D. P; BROWDE, S; KESSEL, I. L et al.International journal of radiation oncology, biology, physics. 1989, Vol 17, Num 2, pp 257-261, issn 0360-3016Article

Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cellsKLEIN, J. L; REY, P. M; BAYNES, R. D et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 9, pp 959-963, issn 0268-3369Article

New concepts in the treatment of breast cancer using high-dose chemotherapyPETERS, W. P; DANSEY, R.Cancer chemotherapy and pharmacology. 1997, Vol 40, pp S88-S93, issn 0344-5704, SUPConference Paper

Non-cryopreserved, limited number (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administration provide adequate hematologic support for high dose chemotherapyBEZWODA, W. R; DANSEY, R; SEYMOUR, L et al.Hematological oncology. 1994, Vol 12, Num 3, pp 101-110, issn 0278-0232Article

Treatment of malignant ascites due to recurrent/refractory ovarian cancer : the use of interferon-α or interferon-α plus chemotherapy in vivo and in vitroBEZWODA, W. R; GOLOMBICK, T; DANSEY, R et al.European journal of cancer (1990). 1991, Vol 27, Num 11, pp 1423-1429, issn 0959-8049Article

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesSAAD, F; BROWN, J. E; BARRIOS, C. H et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1341-1347, issn 0923-7534, 7 p.Article

Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients : a case series and review of the literatureIBRAHIM, R. B; PERES, E; DANSEY, R et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 11, pp 1071-1077, issn 0268-3369, 7 p.Article

Successful allogeneic bone marrow transplantation in selected patients over 50 years of age : A single institution's experienceDU, W; DANSEY, R; ABELLA, E. M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 10, pp 1043-1047, issn 0268-3369Article

Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's diseaseSEYMOUR, L. K; DANSEY, R. D; BEZWODA, W. R et al.British journal of cancer. 1994, Vol 70, Num 3, pp 526-530, issn 0007-0920Article

Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's diseaseDANSEY, R. D; HAMMOND-TOOKE, G. D; LAI, K et al.Medical and pediatric oncology. 1988, Vol 16, Num 4, pp 284-286, issn 0098-1532Article